Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December more...
Evoke Pharma Announces Pricing of Public Offering of Common Stock
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that it has priced an underwritten more...
Evoke Pharma Announces Proposed Public Offering of Common Stock
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that it intends to offer and more...
Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance more...
BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions
Industry-leading smart glasses technology expected to enhance the utility of BioSig’s PURE EP™ System signal processing platform. Remote servicing intended to enable continued installations, upgrades, and training during COVID-19 travel restrictions and lockdown limitations. Westport, more...
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
— Total revenues expected to be $20.8 million for fourth quarter 2020 and $74.2 million for full year 2020 — — Product sales of GOCOVRI ® expected to be $19.8 million for fourth quarter 2020 more...
ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology
Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans Advance ANN ARBOR, MI / ACCESSWIRE / January 13, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of more...
Do Options Traders Know Something About AcelRx (ACRX) Stock We Don’t?
Investors in AcelRx Pharmaceuticals, Inc. ACRX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 19, 2021 $5.00 Call had some of the more...
Evoke Pharma Announces Positive Findings from GIMOTI(TM) Market Research Study
Healthcare practitioner survey indicates physicians’ awareness and intent to prescribe newly-launched product SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (“Evoke” or the “Company”) (NASDAQ: EVOK), a specialty pharmaceutical company focused more...
Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single Assay
Global customer consensus on Saphyr’s capability to identify actionable variants in hematological malignancies detected by several cytogenomic methods combined Saphyr identifies additional variants missed by traditional methods that have prognostic and therapeutic value, with a more...